Fewer people reported needing to miss work after their booster, compared to their second dose.
Rigor académico, oficio periodístico
Artículos sobre Vaccine side effects
Mostrando todos artículos
Myocarditis following COVID-19 vaccination is rare, and the risk is much smaller than the risks of cardiac injury linked to COVID-19 itself.
What do you need to weigh up when working out whether to get the AstraZeneca vaccine? Here’s what the evidence says.
Ongoing tracking is meant to spot very rare risks – like the connection between the Johnson & Johnson shot and Guillain-Barré syndrome. And it relies on public reporting.
If you’re in Sydney, the advice is for people to bring forward the timing of their second AstraZeneca shot, and for the under 60s to consider having it if they can’t get hold of Pfizer.
At the moment, the scheme only applies to health practitioners, not patients.
Experts are continually monitoring how well COVID vaccines are working, their side effects, and the amount of disease in the community. These factors can change, and advice will adapt accordingly.
Australia is now rolling out the Pfizer vaccine to people aged under 50, with the 40-49 age group newly eligible. Here’s what you can expect.
The TGA has reported a handful of cases of the autoimmune disorder Guillain-Barré syndrome following the AstraZeneca vaccine.
A serious event such as a blood clot could be caused by an underlying medical condition, a medication the person was taking at the time, or some other factor unrelated to the vaccine.
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots, and how do they form?
The AstraZeneca COVID vaccine is now available to Australians over 50. Here’s what you need to know before you roll up your sleeve.
As Australian women over 50 prepare to have their COVID shot, they need to factor in timing of their mammogram. Here’s why.
It’s normal for different people to mount stronger or weaker immune responses to a vaccine, but post-shot side effects won’t tell you which you are.
Many people never experience the least bit of discomfort from the COVID-19 vaccines, but mild side effects are common. They include swelling in the affected arm, nausea and chills.
Pausing COVID-19 vaccine rollouts can backfire. There are better ways to manage safety issues while they’re being investigated.
Years of vaccine research tells us that, if side effects are going to occur, they normally occur within the first months after getting a vaccine.
We already track potential vaccine side-effects in Australia. So we’ll be using, and building on, years of experience in monitoring any long-term effects of COVID-19 vaccines.
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
Principales colaboradores
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Paediatrician, Infectious Diseases Physician and Clinical Microbiologist, Telethon Kids Institute, The University of Western Australia
-
Paediatrician, National Centre for Immunisation Research and Surveillance; Clinical Lecturer, Children's Hospital Westmead Clinical School, University of Sydney
-
Adjunct Professor, Australian Centre for Health Law Research, School of Law, Queensland University of Technology
-
Associate Professor, Australian Centre for Health Law Research, Queensland University of Technology
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Professor of Breast Cancer Research, Institute of Health and Biomedical Innovation and School of Biomedical Sciences,, Queensland University of Technology
-
Research Fellow in Applied Moral Philosophy, University of Oxford
-
Senior Research Officer, Telethon Kids Institute
-
Associate Professor of Infectious Diseases, Immunisation and Emergencies (IDIE) at Sydney School of Public Health, University of Sydney
-
Professor, Laboratory of Molecular Cardiology, University of Guelph
-
Associate Professor, Infectious Diseases and Microbiology, The University of Queensland
